Individual holder
BORODIC GARY E
US·10 granted patents·9 pending applications·196 citations·filing 1989–2024
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
19 records- 0196US8926991B2Botulinum toxin and the treatment of primary disorders of mood and affectBORODIC GARY E·Filed 2006·Granted Jan 6, 2015·18 cites·19 claims
- 0291US8192979B2Compositions, methods and devices for preparing less painful Botulinum toxin formulationsBORODIC GARY E·Filed 2005·Granted Jun 5, 2012·11 cites·21 claims
- 0391US7270826B2Methods of using Botulinum toxin for the treatment of hypervolemic lip deformity (lip ectropion)BORODIC GARY E·Filed 2005·Granted Sep 18, 2007·9 cites·8 claims
- 0489US9066851B2Extended length botulinum toxin formulation for human or mammalian useBORODIC GARY E·Filed 2009·Granted Jun 30, 2015·10 cites·6 claims
- 0588US8679486B2High-potency botulinum toxin formulationsBORODIC GARY E·Filed 2010·Granted Mar 25, 2014·9 cites·8 claims
- 0683US11123411B2Method of treating macular degeneration using botulinum toxin-based pharmaceuticalsBORODIC GARY E·Filed 2017·Granted Sep 21, 2021·1 cites·18 claims
- 0777US9393291B2Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory bedsBORODIC GARY E·Filed 2013·Granted Jul 19, 2016·1 cites·18 claims
- 0876US5053005AChemomodulation of curvature of the juvenile spineBORODIC GARY E·Filed 1989·Granted Oct 1, 1991·137 cites·7 claims
- 0973US2024189402A1Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based PharmaceuticalsBORODIC GARY E·Filed 2024·Application pending·0 cites
- 1070US2009148476A1Chemodenervating pharmaceutical as anti-inflammatory agentBORODIC GARY E·Filed 2008·Application pending·0 cites
- 1165US11123412B2Method of treating macular degeneration using botulinum toxin-based pharmaceuticalsBORODIC GARY E·Filed 2018·Granted Sep 21, 2021·0 cites·10 claims
- 1264US2010278867A1Use of botulinum toxin for the treatment of chronic facial painBORODIC GARY E·Filed 2006·Application pending·0 cites
- 1361US2020368331A1Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based PharmaceuticalsBORODIC GARY E·Filed 2020·Application pending·0 cites
- 1458US2014315820A1High-Potency Botulinum Toxin FormulationsBORODIC GARY E·Filed 2014·Application pending·0 cites
- 1549US11096993B2Method of treating macular degeneration using botulinum toxin-based pharmaceuticalsBORODIC GARY E·Filed 2018·Granted Aug 24, 2021·0 cites·18 claims
- 1646US2020046813A1Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based PharmaceuticalsBORODIC GARY E·Filed 2018·Application pending·0 cites
- 1745US2009324647A1Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing a Hyaluronidase and Methods of UseBORODIC GARY E·Filed 2006·Application pending·0 cites
- 1842US2018344806A1Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based PharmaceuticalsBORODIC GARY E·Filed 2018·Application pending·0 cites
- 1939US2011319944A1Submuscular Facial Fixation (Myo-Osseous Fixation) Using Microincision Microscrew Device, Injectable Glues and Adhesives, and Method and Device for Therapy of Migraine and Related HeadachesBORODIC GARY E·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BORODIC GARY E files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →